Movement Patterns in Young Volleyball Athletes

November 2, 2020 updated by: Prof. Dr. F. Staes, Universitaire Ziekenhuizen KU Leuven

Optimizing Body and Movement Specific Characteristics in Volleyball Players to Reduces Injuries in Young Athletes.

This project is a consequence of the research chair project studying the same phenomenon in adult volleyball players. The project will make use of and be part of the routine medical screening that is taken by the young players of the first degree of the Leuven Volleyball School, Belgium. All young players must undergo a routine medical investigation and movement screening. This is obliged by the law. The current project will use these data. Outcome parameters will be used to advice the trainer staff of the school to adjust their training interventions. This is normal routine too as the involved medical department has been advising the school for many years. Players will be followed up for 6 weeks. After those 6 weeks, the movement screening will be repeated to evaluate the change in the different outcome parameters. This last screening is not part of a normal routine as players normally are investigated more in a subjective way. The medical team and school want to change that routine.

Data will be used to further improve training modalities and sports performance and reduce injury risk in these young athletes.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, 3000
        • UZ Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All students from the first degree of the Volleyball school will participate
  • Male and female athletes will be included
  • Signing of an informed consent and assent form (for young kids) to use data for research
  • Agreement given by the medical staff to use data and allowing the kids to be accepted by the school

Exclusion Criteria:

  • When inclusion criteria are not met

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Training intervention
See information elsewhere

Based on the baseline screening, which is part of the normal prevention routine within the school, all athletes are given individual advice with regard to points of attention within training. For example: those athletes with reduced balance, will get more balance training.

Intervention is individual as said and will be guided and supervised by the physical trainer and medical staff of the school.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of joint mobility
Time Frame: Difference between baseline and 6 weeks
Mobility will be assessed by using goniometer measurements (degrees of movement)
Difference between baseline and 6 weeks
Change of strength
Time Frame: Difference between baseline and 6 weeks
Strength will be assessed by using handheld dynamo-meter data (Newton)
Difference between baseline and 6 weeks
Change in balance score
Time Frame: Difference between baseline and 6 weeks
Stability is measured using the score on the Star Excursion Balance Test (numeric score on balance scale)
Difference between baseline and 6 weeks
Change in lower limb joint angles during a single leg drop vertical jump
Time Frame: Difference between baseline and 6 weeks
Movement quality is measured using joint angles (trunk, pelvis, hip, knee, ankle)
Difference between baseline and 6 weeks
Change in lumbopelvic stability score
Time Frame: Difference between baseline and 6 weeks
Lumbopelvic stability is scored using 9 clinical tests (Bend knee fall out, Active straight leg raise, prone knee bend, sitting knee extension, standing bow, pelvic tilt, one leg stance, backward rocking, forward rocking). Each test is given a score between 0 (poor performance) and 2 (good performance) adding up to a total score of 18.
Difference between baseline and 6 weeks
Change in lower limb joint angles during a drop jump
Time Frame: Difference between baseline and 6 weeks
Movement quality is measured using joint angles (trunk, pelvis, hip, knee, ankle)
Difference between baseline and 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Individualized web diagram of all outcome measurements
Time Frame: Baseline
Baseline data on joint mobility (joint angles), strength (N), balance (Star Excursion Balance Test Score, lumbopelvic control scores) and joint angles during a drop jump and single leg drop vertical jump) are all visualized on a web diagram per athlete
Baseline
Number of injuries
Time Frame: Baseline information from medical investigation
Description of number of injuries
Baseline information from medical investigation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Filip F Staes, prof, KU Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2017

Primary Completion (Actual)

December 23, 2018

Study Completion (Actual)

December 23, 2018

Study Registration Dates

First Submitted

September 10, 2017

First Submitted That Met QC Criteria

September 14, 2017

First Posted (Actual)

September 15, 2017

Study Record Updates

Last Update Posted (Actual)

November 3, 2020

Last Update Submitted That Met QC Criteria

November 2, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • S60760

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

No individual data will be shared with other researchers. Data will be available to the medical and trainers staff. For research purposes, all data will be made anonymous.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Training

Clinical Trials on Training intervention

Subscribe